Belgium looks to launch limited vaccine campaign in January
Belgium is planning to launch a COVID-19 vaccination campaign on a limited scale starting in early January
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Belgium plans to launch a COVID-19 vaccination campaign on a limited scale starting in early January and initially will use the shots developed by Pfizer and BioNtech, health authorities said Thursday.
The small country with some 11.5 million inhabitants has been severely hit by the coronavirus, reporting more than 580,000 cases and nearly 17,000 virus-related deaths since the start of the pandemic.
Belgium’s health ministers said the national immunization strategy will be rolled out in phases, depending on the number of doses available. During the first phase, 600,000 doses of the Pfizer/BioNtech vaccine will be used, enough for 300,000 people since each person needs two shots.
European regulators are likely to authorize the first COVID-19 vaccines by the end of December or early January, and Belgium wants to start giving them to people soon after. Both BioNTech Pfizer and Moderna submitted conditional marketing authorization applications to the European Medicines Agency this week.
In Belgium, residents and staff of care centers for elderly people will get priority access to vaccines along with frontline health care workers. Other people over age 65 or at high risk for the virus will be vaccinated at a later stage, when vaccines that can be stocked under less stringent refrigeration standards are available. The general population considered to be at low risk will have to wait longer.
“It means that we won't have a majority of citizens vaccinated before the summer," said Dirk Ramaekers, who heads the country's vaccination task force.
The European Union's executive commission has secured deals with Moderna, AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNTech-Pfizer and CureVac to allow EU member nations to purchase up to 2 billion vaccine doses. The commission said once a vaccine is authorized, members should get access to it at the same time, on a pro rata basis,